JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265914

Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

COL4A6 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 24 and 2 bp deletion in exon 24 and 4 bp deletion in exon 24. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

COL4A6, Collagen Alpha 6(IV), Collagen IV alpha 6 polypeptide, Collagen alpha 6(IV) chain, Collagen of basement membrane alpha 6, Collagen type IV alpha 6, MGC88184, Type IV alpha 6 collagen, dJ889N15.4

3 Images
Sanger Sequencing - Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line (AB265914)
  • Sanger seq

Unknown

Sanger Sequencing - Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line (AB265914)

Allele-1 : 4 bp deletion in exon 24.

Sanger Sequencing - Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line (AB265914)
  • Sanger seq

Unknown

Sanger Sequencing - Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line (AB265914)

Allele-2 : 2 bp deletion in exon 24.

Sanger Sequencing - Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line (AB265914)
  • Sanger seq

Unknown

Sanger Sequencing - Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line (AB265914)

Allele-3 : 1 bp insertion in exon 24.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 24 and 2 bp deletion in exon 24 and 4 bp deletion in exon 24

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265914-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265914 Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line", "number":"AB265914-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265914-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265914-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265914 Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line", "number":"AB265914-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265914-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265914-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265914 Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line", "number":"AB265914-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265914-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265914 Human COL4A6 (Collagen IV alpha 6) knockout HeLa cell line", "number":"AB265914-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
COL4A6
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Collagen IV alpha 6 also known as COL4A6 forms a part of the collagen IV family. This protein acts as a structural component in the basement membrane playing a role in maintaining the integrity and stability of these membranes. Weighing about 160 kDa COL4A6 is expressed in a variety of tissues such as the kidney lung and testis. The local expression in these tissues suggests its key role in supporting organ-specific structures.
Biological function summary

As part of the collagen IV network COL4A6 contributes to the formation of the heterotrimeric type IV collagen molecules. These trimers are composed of three alpha chains that associate to form a complex structure necessary for providing mechanical support and filtration functions in the basement membrane. The involvement of COL4A6 in these processes highlights its important role in tissue morphogenesis and maintenance.

Pathways

The function of COL4A6 integrates into major signaling cascades like the integrin-mediated signaling pathway and the extracellular matrix (ECM) remodeling pathway. Within these pathways COL4A6 collaborates with other collagen IV proteins such as COL4A1 and COL4A5 to interact with integrins. These interactions are critical for signal transduction processes that regulate cell adhesion migration and differentiation thereby maintaining tissue architecture.

Mutations or alterations in COL4A6 are linked to Alport syndrome and some forms of nephropathy. In Alport syndrome there is a direct connection with COL4A5 another collagen IV family member which often coexists with COL4A6 in forming critical basement membrane structures. Dysfunction in these proteins leads to compromised membrane stability and filtration resulting in the characteristic symptoms of kidney disease and hearing loss seen in affected individuals.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com